SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 183 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $203,273 | -98.2% | 1,775 | -98.8% | 0.01% | -99.2% |
| Q3 2019 | $11,219,000 | +183.0% | 148,947 | +396.5% | 0.84% | +310.7% |
| Q2 2018 | $3,965,000 | +22.3% | 30,000 | -31.5% | 0.20% | +48.6% |
| Q1 2018 | $3,243,000 | -12.9% | 43,767 | -34.6% | 0.14% | -29.2% |
| Q4 2017 | $3,722,000 | -45.3% | 66,891 | -55.4% | 0.20% | -43.1% |
| Q3 2017 | $6,805,000 | +134.4% | 150,023 | +74.2% | 0.34% | +118.5% |
| Q2 2017 | $2,903,000 | -13.6% | 86,100 | -24.1% | 0.16% | -5.4% |
| Q1 2017 | $3,360,000 | -60.2% | 113,500 | -63.1% | 0.17% | -70.3% |
| Q4 2016 | $8,432,000 | +3034.6% | 307,400 | +6926.3% | 0.56% | +3620.0% |
| Q3 2016 | $269,000 | -95.8% | 4,375 | -98.7% | 0.02% | -95.5% |
| Q2 2016 | $6,459,000 | +41.9% | 338,675 | +138.8% | 0.34% | -13.6% |
| Q3 2015 | $4,553,000 | +92.8% | 141,813 | +183.6% | 0.39% | +76.5% |
| Q3 2013 | $2,361,000 | -19.9% | 50,000 | -35.5% | 0.22% | -26.6% |
| Q2 2013 | $2,948,000 | – | 77,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |